Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Ryan

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
The American Journal of Tropical Medicine and Hygiene|June 8, 2018
Importance of Proactive Malaria Case Surveillance and Management in MalaysiaJonathan Wee Kent Liew, Rizawati Binti Mahpot, Shairah Dzul, et al.
Haematologica|March 21, 2024
Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myelomaLyndsey Flanagan, Aisling Coughlan, Nicola Cosgrove, et al.
Cancers|March 6, 2021
Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 ProfilingRyan N Rys, Claudia M Wever, Dominique Geoffrion, et al.
JCI Insight|August 9, 2019
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumorMichael V Ortiz, Saima Ahmed, Melissa Burns, et al.
Cell Death & Disease|July 31, 2019
Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signalingFelix Seyfried, Salih Demir, Rebecca Louise Hörl, et al.
Scientific Reports|July 10, 2019
Whole genome sequencing of amplified Plasmodium knowlesi DNA from unprocessed blood reveals genetic exchange events between Malaysian Peninsular and Borneo subpopulationsErnest Diez Benavente, Ana Rita Gomes, Jeremy Ryan De Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and DecitabineEvan C Chen, Yiwen Liu, Hayden L Bell, et al.
Cell Death and Differentiation|December 26, 2025
Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanismsMaria Davern, Cole J Turner, Daryl Griffin, et al.
Ecology|May 27, 2020
Full lifetime perspectives on the costs and benefits of lay-date variation in tree swallowsDavid W Winkler, Kelly K Hallinger, Teresa M Pegan, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemiaEmma-Jayne Minihane, Leah Krotee, Jason Wu, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
The American Journal of Tropical Medicine and Hygiene|June 8, 2018
Importance of Proactive Malaria Case Surveillance and Management in MalaysiaJonathan Wee Kent Liew, Rizawati Binti Mahpot, Shairah Dzul, et al.
Haematologica|March 21, 2024
Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myelomaLyndsey Flanagan, Aisling Coughlan, Nicola Cosgrove, et al.
Cancers|March 6, 2021
Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 ProfilingRyan N Rys, Claudia M Wever, Dominique Geoffrion, et al.
JCI Insight|August 9, 2019
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumorMichael V Ortiz, Saima Ahmed, Melissa Burns, et al.
Cell Death & Disease|July 31, 2019
Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signalingFelix Seyfried, Salih Demir, Rebecca Louise Hörl, et al.
Scientific Reports|July 10, 2019
Whole genome sequencing of amplified Plasmodium knowlesi DNA from unprocessed blood reveals genetic exchange events between Malaysian Peninsular and Borneo subpopulationsErnest Diez Benavente, Ana Rita Gomes, Jeremy Ryan De Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and DecitabineEvan C Chen, Yiwen Liu, Hayden L Bell, et al.
Cell Death and Differentiation|December 26, 2025
Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanismsMaria Davern, Cole J Turner, Daryl Griffin, et al.
Ecology|May 27, 2020
Full lifetime perspectives on the costs and benefits of lay-date variation in tree swallowsDavid W Winkler, Kelly K Hallinger, Teresa M Pegan, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemiaEmma-Jayne Minihane, Leah Krotee, Jason Wu, et al.
Pageof 7